                         SEQUENCE LISTING

<110>  B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., at 
       Ben-Gurion University
       THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
 
<120>  ANALOGUES OF VDAC1-DERIVED PEPTIDES

<130>  NIBN/002 PCT

<150>  62/213667
<151>  2015-09-03

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Lys Lys Leu Glu Thr Ala Val Asn Leu Ala Trp Thr Ala Gly Asn Ser 
1               5                   10                  15      


Asn 
    


<210>  2
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Asn Ser Asn Gly Ala Thr Trp Ala Leu Asn Val Ala Thr Glu Leu Lys 
1               5                   10                  15      


Lys 
    


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  D-amino acid

<400>  3

Asn Ser Asn Gly Ala Thr Trp Ala Leu Asn Val Ala Thr Glu Leu Lys 
1               5                   10                  15      


Lys 
    


<210>  4
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Met Ala Val Pro Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp 
1               5                   10                  15      


Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
            20                  25      


<210>  5
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Leu Gly Phe Gly Tyr Gly Lys Thr Phe Val Asp Arg Ala Ser Lys Gly 
1               5                   10                  15      


Leu Asp Ala Tyr Thr Pro Pro Val Ala Met 
            20                  25      


<210>  6
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  D-amino acid

<400>  6

Leu Gly Phe Gly Tyr Gly Lys Thr Phe Val Asp Arg Ala Ser Lys Gly 
1               5                   10                  15      


Leu Asp Ala Tyr Thr Pro Pro Val Ala Met 
            20                  25      


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

His Ala Ile Tyr Pro Arg His 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

His Arg Pro Tyr Ile Ala His 
1               5           


<210>  9
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Lys Lys Trp Lys Met Arg Arg Asn Gln Phe Trp Ile Lys Ile Gln Arg 
1               5                   10                  15      


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Ser Trp Thr Trp Glu 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Lys Trp Thr Trp Lys 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Glu Trp Thr Trp Ser 
1               5   


<210>  14
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(27)
<223>  D-amino acid

<400>  14

Lys Trp Thr Trp Lys Asn Ser Asn Gly Ala Thr Trp Ala Leu Asn Val 
1               5                   10                  15      


Ala Thr Glu Leu Lys Lys Glu Trp Thr Trp Ser His Arg Pro Tyr Ile 
            20                  25                  30          


Ala His 
        


<210>  15
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(42)
<223>  D-amino acid

<400>  15

Lys Lys Trp Lys Met Arg Arg Asn Gln Phe Trp Ile Lys Ile Gln Arg 
1               5                   10                  15      


Leu Gly Phe Gly Tyr Gly Lys Thr Phe Val Asp Arg Ala Ser Lys Gly 
            20                  25                  30          


Leu Asp Ala Tyr Thr Pro Pro Val Ala Met 
        35                  40          


<210>  16
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(42)
<223>  D-amino acid

<400>  16

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Leu Gly Phe Gly Tyr Gly Lys Thr Phe Val Asp Arg Ala Ser Lys Gly 
            20                  25                  30          


Leu Asp Ala Tyr Thr Pro Pro Val Ala Met 
        35                  40          


<210>  17
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(34)
<223>  D-amino acid

<400>  17

His Ala Ile Tyr Pro Arg His Ser Trp Thr Trp Glu Lys Lys Leu Glu 
1               5                   10                  15      


Thr Ala Val Asn Leu Ala Trp Thr Ala Gly Asn Ser Asn Lys Trp Thr 
            20                  25                  30          


Trp Lys 
        


<210>  18
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(28)
<223>  D-amino acid

<400>  18

Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu Arg Gln Ile Lys 
1               5                   10                  15      


Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
            20                  25              


<210>  19
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(22)
<223>  D-amino acid

<400>  19

Lys Trp Thr Trp Lys Asn Ser Asn Gly Ala Thr Trp Ala Leu Asn Val 
1               5                   10                  15      


Ala Thr Glu Leu Lys Lys Glu Trp Thr Trp Ser His Arg Pro Tyr Ile 
            20                  25                  30          


Ala His 
        


